Breast cancer could be detected up to five years before there are any clinical signs of it, using a blood test that identifies the body’s immune response to substances produced by tumour cells, according to new research presented at the 2019 NCRI Cancer Conference today (Sunday).
Cancer cells produce proteins called antigens that trigger the body to make antibodies against them – autoantibodies. Researchers at the University of Nottingham (UK) have found that these tumour-associated antigens (TAAs) are good indicators of cancer, and now they have developed panels of TAAs that are known already to be associated with breast cancer to detect whether or not there are autoantibodies against them in blood samples taken from patients.
In a pilot study the researchers, who are part of the Centre of Excellence for Autoimmunity in Cancer (CEAC) group at the School of Medicine, University of Nottingham, took blood samples from 90 breast cancer patients at the time they were diagnosed with breast cancer and matched them with samples taken from 90 patients without breast cancer (the control group).
They used screening technology (protein microarray) that allowed them to screen the blood samples rapidly for the presence of autoantibodies against 40 TAAs associated with breast cancer, and also 27 TAAs that were not known to be linked with the disease.
Presenting the research at the NCRI Conference, Ms Daniyah Alfattani, a PhD student in the group, said: “The results of our study showed that breast cancer does induce autoantibodies against panels of specific tumour-associated antigens. We were able to detect cancer with reasonable accuracy by identifying these autoantibodies in the blood.”
The researchers identified three panels of TAAs against which to test for autoantibodies. The accuracy of the test improved in the panels that contained more TAAs. The panel of five TAAs correctly detected breast cancer in 29% of the samples from the cancer patients and correctly identified 84% of the control samples as being cancer-free. The panel of seven TAAs correctly identified cancer in 35% of cancer samples and no cancer in 79% of control samples. The panel of nine antigens correctly identified cancer in 37% of cancer samples and no cancer in 79% of the controls.
“We need to develop and further validate this test,” said Ms Alfattani. “However, these results are encouraging and indicate that it’s possible to detect a signal for early breast cancer. Once we have improved the accuracy of the test, then it opens the possibility of using a simple blood test to improve early detection of the disease.”
The researchers are now testing samples from 800 patients against a panel of nine TAAs, and they expect the accuracy of the test to improve with these larger numbers.
“A blood test for early breast cancer detection would be cost effective, which would be of particular value in low and middle income countries. It would also be an easier screening method to implement compared to current methods, such as mammography,” said Ms Alfattani.
The researchers estimate that, with a fully-funded development programme, the test might become available in the clinic in about four to five years.
A similar test for lung cancer is currently being tested in a randomised controlled trial in Scotland, involving 12,000 people at high risk of developing lung cancer because they smoke. They have been randomised to have (or not) an autoantibody blood test called ELISA (Early CDT-Lung). Participants who test positive for the autoantibodies are then followed up with a CT scan every two years in order to detect lung cancer in its early stages when it is easier to treat.
The CEAC group is also working on similar tests for pancreatic, colorectal and liver cancers. Solid tumours like these, as well as lung and breast cancer, represent around 70% of all cancers.
“A blood test capable of detecting any of these cancers at an early stage is the over-riding objective of our work,” concluded Ms Alfattani.
Dr Iain Frame, CEO of NCRI said: “Early diagnosis using simple, non-invasive ways of detecting the first signs of cancer is a key strategic priority for NCRI and something we’d all like to see working in practice. The results from this pilot study for a blood test to detect early breast cancer are promising and build on this research group’s expertise in other cancers, such as lung cancer. It’s obviously early days but we look forward to seeing the results from the larger group of patients that are now being investigated.”
The Latest on: Breast cancer
via Google News
The Latest on: Breast cancer
- Sarah Harding returns to social media to update fans on cancer battleon February 23, 2021 at 9:19 am
Sarah Harding has thanked fans for their support during her breast cancer battle. Like us on Facebook to see similar stories Please give an overall site rating: ...
- Markey's ACTION program develops cancer education curriculum for Appalachian schoolson February 23, 2021 at 9:12 am
After conducting a study to assess the need for cancer education materials in Appalachian Kentucky, members of the University of Kentucky Markey Cancer Center's Appalachian Career Training in Oncology ...
- Hologic completes $230M acquisition of California cancer test companyon February 23, 2021 at 9:10 am
Hologic has completed its purchase of San Diego cancer testing company Biotheranostics, Inc., the Marlborough medical technology company announced late Monday.
- UVA researchers discover breast cancer breakthrough that could help save liveson February 23, 2021 at 8:03 am
Researchers at the University of Virginia have identified a gene that spreads “triple-negative” breast cancer to other parts of the body.
- ‘It Broke My Heart': Cancer Patient Reacts to News She Won't Be Eligible for COVID Vaccine Until Aprilon February 23, 2021 at 7:52 am
People with underlying conditions, those considered high-risk, are no longer next to get the coronavirus vaccine. A cancer survivor and current fighter is wondering why she’s no longer a priority.
- Breast cancer: is milk a risk factor?on February 23, 2021 at 7:06 am
The first study, which looked at 33,780 Swedish women since 1997, found that about 300 millilitres of cow’s milk per day (the equivalent of a large mug) increased breast cancer risk by about a ...
- Tucson business provides bras, prosthetics for breast cancer survivorson February 23, 2021 at 4:47 am
"Our business is kind of unique because we don't have one age group of customers that we service," said Hann. Hann said her shop serves young teens to those later in life. The Tucson shop provides ...
- COVID-19 and Mammogram Breast Cancer Screening: What You Should Knowon February 23, 2021 at 3:26 am
Dr. Phoebe Freer, a radiologist at Huntsman Cancer Institute and chief of breast imaging in the Department of Radiology and Imaging Sciences at University of Utah Health, provides insight on breast ...
- Shannen Doherty goes shopping with her mother in Malibu amid stage IV breast cancer battleon February 23, 2021 at 2:20 am
The Charmed actress, 49, dressed down in a simple camel sweater, black trousers and a blue face covering for the shopping trip in Malibu on Monday.
- Woman who had a preventative double mastectomy at 33 after watching her grandmother and mom battle breast cancer, and facing TWO scares herself, says surgery made her feel ...on February 22, 2021 at 1:41 pm
Bess Jones, now 34, from Ohio, underwent a preventative double mastectomy in 2020, after facing two breast cancer scares within months.
via Bing News